DEF 14A: BioMarin Seeks Stockholder Approval for Equity Incentive Plan Amendment

BioMarin is asking stockholders to approve an amendment to its 2017 Equity Incentive Plan to increase the number of shares reserved for issuance.

Summary

• BioMarin is seeking stockholder approval to amend its 2017 Equity Incentive Plan to increase the number of shares reserved for issuance by 8,000,000.
• The company believes this amendment is crucial for attracting and retaining talent, aligning employee interests with those of stockholders, and maintaining competitive compensation practices.
• The document highlights that BioMarin's equity grant practices are broad-based, with a significant portion of equity grants allocated to employees other than named executive officers (NEOs).
• The company's average burn rate for the last three years is reported as 1.8%, which is lower than the median of its peer group.
• If the amendment is not approved, BioMarin anticipates potential difficulties in attracting and retaining talent, which could negatively impact the company's performance and stockholder value.
• The amended plan includes provisions designed to protect stockholder interests, such as prohibiting repricing of stock options without stockholder approval, restrictions on dividend payments for unvested shares, and clawback policies.

Sentiment

Score: 7

Explanation: The document is generally positive, focusing on the need to attract and retain talent and the company's commitment to responsible equity compensation practices. However, it also acknowledges potential risks if the amendment is not approved.

Positives

• The proposed amendment aims to ensure BioMarin can continue to attract and retain top talent.
• The company's equity grant practices are broad-based, extending beyond executive leadership.
• BioMarin's historical share usage has been responsible, with a low average burn rate.
• The amended plan incorporates corporate governance best practices to protect stockholder interests.
• The company is committed to providing regular opportunities for stockholders to review equity grant practices.

Negatives

• Failure to approve the amendment could hinder BioMarin's ability to attract and retain talent.
• The company may need to replace equity compensation with cash, increasing expenses and potentially impacting cash flow.
• The document notes that the performance-based compensation exception under Section 162(m) of the Code has been repealed, limiting tax deductibility of executive compensation.

Risks

• If the amendment is not approved, BioMarin may face challenges in attracting and retaining qualified employees.
• The company's ability to achieve its strategic objectives and create long-term stockholder value could be negatively impacted by limitations on equity compensation.
• Changes in tax laws, such as the repeal of the performance-based compensation exception under Section 162(m) of the Code, could affect the company's ability to deduct executive compensation expenses.

Future Outlook

The company estimates that the amended plan will provide sufficient shares for approximately two years, depending on growth and share price.

Management Comments

• A talented, motivated and effective management team and workforce are essential to the Company’s continued progress.
• Equity compensation has been an important component of total compensation at the Company for many years because it is effective at getting employees to think and act like owners.

Industry Context

The document benchmarks BioMarin's burn rate and dilution against its peer group, indicating an awareness of industry standards for equity compensation.

Comparison to Industry Standards

• The document compares BioMarin's burn rate to the median of its 2024 Peer Group.
• The document compares BioMarin's total dilution to the median of its 2024 Peer Group.
• The document references Radford Global Life Sciences Compensation survey and additional survey sources from the Compensation Consultant.

Corporate Governance

Stakeholder Impact

• Approval of the amendment is expected to benefit stockholders by ensuring the company can attract and retain talent, driving long-term value creation.
• Employees would benefit from continued access to equity compensation, aligning their interests with those of stockholders.
• Failure to approve the amendment could negatively impact the company's ability to compete for talent, potentially affecting its performance and stakeholder value.

Next Steps

• Stockholder vote on the proposed amendment to the 2017 Equity Incentive Plan at the Annual Meeting on May 20, 2025.

Key Dates

Keywords

Equity Incentive Plan, Stockholder Approval, Compensation, Equity Awards, Burn Rate, Dilution, Corporate Governance, Executive Compensation, BioMarin